Disease | small cell carcinoma |
Symptom | C0220650|brain metastasis |
Sentences | 15 |
PubMedID- 20169130 | Aggressive trimodality therapy for t1n2m1 nonsmall cell lung cancer with synchronous solitary brain metastasis: case report and rationale. |
PubMedID- 19592127 | Background: the optimal treatment for non-small cell lung cancer (nsclc) patients with asymptomatic brain metastasis is still controversial. |
PubMedID- 24345489 | Methods: the clinical data of 46 non-small cell lung cancer patients with synchronous solitary brain metastasis were retrospectively reviewed. |
PubMedID- 22580972 | Aggressive treatment for both the primary site and brain metastasis may therefore be an effective treatment for locally advanced non-small cell lung cancer patients with synchronous solitary brain metastasis. |
PubMedID- 26498354 | Greater efficacy of chemotherapy plus bevacizumab compared to chemo- and targeted therapy alone on non-small cell lung cancer patients with brain metastasis. |
PubMedID- 25749580 | Fighting cancer on all fronts: stereotactic radiosurgery and the role for aggressive primary treatment in non-small cell lung cancer patients with one brain metastasis. |
PubMedID- 24864257 | Clinical studies using fotemustine have been conducted in malignant glioma, brain metastasis of non-small cell lung cancer, and disseminated malignant melanoma. |
PubMedID- 24495594 | Definitive chemoradiation therapy following surgical resection or radiosurgery plus whole-brain radiation therapy in non-small cell lung cancer patients with synchronous solitary brain metastasis: a curative approach. |
PubMedID- 25579245 | Background: the appropriate treatment of non-small cell lung cancer (nsclc) with single brain metastasis (sbm) is still controversial. |
PubMedID- 25735792 | Activity of pemetrexed-based regimen as first-line chemotherapy for advanced non-small cell lung cancer with asymptomatic inoperable brain metastasis: a retrospective study. |
PubMedID- 22984665 | The histological distribution was as follows: two falx meningioma, six glioblastoma multiform (gbm), two anaplastic oligodendroglioma, one low grade oligodendroglioma, and one small cell lung cancer with brain metastasis. |
PubMedID- 26014133 | Background: non-small cell lung cancer (nsclc) with brain metastasis (bm) harboring an epidermal growth factor receptor (egfr) mutation shows good response to tyrosine kinase inhibitors (tkis). |
PubMedID- 24077347 | Associations between single-nucleotide polymorphisms in the pi3k-pten-akt-mtor pathway and increased risk of brain metastasis in patients with non-small cell lung cancer. |
PubMedID- 23467694 | Objective: to assess prognostic factors and validate the effectiveness of recursive partitioning analysis (rpa) classes and graded prognostic assessment (gpa) in 290 non-small cell lung cancer (nsclc) patients with brain metastasis (bm). |
PubMedID- 25510753 | Efficacy of surgical treatment for brain metastasis in patients with non-small cell lung cancer. |
Page: 1